Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program ; volume:16 ; number:1 ; day:7 ; month:11 ; year:2016 ; pages:1-11 ; date:12.2016
BMC cancer ; 16, Heft 1 (7.11.2016), 1-11, 12.2016
- Beteiligte Personen und Organisationen
-
Sevilla, Isabel
Segura, Ángel
Capdevila, Jaume
Lopez, Carlos
Garcia-Carbonero, Rocio
Grande, Enrique
SpringerLink (Online service)
- DOI
-
10.1186/s12885-016-2901-1
- URN
-
urn:nbn:de:1111-201612016342
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sevilla, Isabel
- Segura, Ángel
- Capdevila, Jaume
- Lopez, Carlos
- Garcia-Carbonero, Rocio
- Grande, Enrique
- SpringerLink (Online service)
Ähnliche Objekte (12)
Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis
Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
Somatostatin analogues labeled with copper radioisotopes: current status
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
Current Management of Neuroendocrine Tumour Liver Metastases
Paraneoplastic Cushing Syndrome in Gastrointestinal Neuroendocrine Tumour
Peptides in oncology, 2.. Somatostatin analogues and Bombesin antagonists : with 14 tables
Peptides in oncology, 3.. Somatostatin and LH-RH analogues : with 14 tables
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Somatostatin receptor PET/CT in the management of patients with neuroendocrine tumors
Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis
Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
Somatostatin analogues labeled with copper radioisotopes: current status
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
Current Management of Neuroendocrine Tumour Liver Metastases
Paraneoplastic Cushing Syndrome in Gastrointestinal Neuroendocrine Tumour
Peptides in oncology, 2.. Somatostatin analogues and Bombesin antagonists : with 14 tables
Peptides in oncology, 3.. Somatostatin and LH-RH analogues : with 14 tables
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Somatostatin receptor PET/CT in the management of patients with neuroendocrine tumors
Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis
Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
Somatostatin analogues labeled with copper radioisotopes: current status
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
Current Management of Neuroendocrine Tumour Liver Metastases
Paraneoplastic Cushing Syndrome in Gastrointestinal Neuroendocrine Tumour
Peptides in oncology, 2.. Somatostatin analogues and Bombesin antagonists : with 14 tables
Peptides in oncology, 3.. Somatostatin and LH-RH analogues : with 14 tables
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly